Evidence map›Paper›PMID 29017600›Full record

ArticleJournal of nanobiotechnology2017

Ions doped melanin nanoparticle as a multiple imaging agent.

Shin-Woo Ha, Hee-Sang Cho, Young Il Yoon, Moon-Sun Jang, Kwan Soo Hong, Emmanuel Hui, Jung Hee Lee, Tae-Jong Yoon

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Recent Trends in Biomedical Applications of CuInternational journal of nanomedicine · 2025
    Review
  2. Review
  3. Review
  4. Radiopharmaceutical and EuJournal of nanobiotechnology · 2021
    Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shin-Woo HaMedical Device R&D Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, 13605, South Korea.
Hee-Sang ChoNanopharmacy Lab., College of Pharmacy and Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, 206 Worldcup-ro, Yeongtong-gu, Suwon, 16499, South Korea.
Young Il YoonMedical Device R&D Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, 13605, South Korea.
Moon-Sun JangDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, South Korea.
Kwan Soo HongBioimaging Research Team, Korea Basic Science Institute, Cheongju, 28119, South Korea.
Emmanuel HuiMoogene Medi Co. Ltd., Gwankyo-ro 147, Gyeonggi-Bio-Center, Yeongtong-gu, Suwon, 16229, South Korea.
Jung Hee LeeDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, South Korea. hijunghee@skku.edu.
Tae-Jong YoonNanopharmacy Lab., College of Pharmacy and Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, 206 Worldcup-ro, Yeongtong-gu, Suwon, 16499, South Korea. tjyoon@ajou.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultimodal nanomaterials are useful for providing enhanced diagnostic information simultaneously for a variety of in vivo imaging methods. According to our research findings, these multimodal nanomaterials offer promising applications for cancer therapy.

resultsMelanin nanoparticles can be used as a platform imaging material and they can be simply produced by complexation with various imaging active ions. They are capable of specifically targeting epidermal growth factor receptor (EGFR)-expressing cancer cells by being anchored with a specific antibody. Ion-doped melanin nanoparticles were found to have high bioavailability with long-term stability in solution, without any cytotoxicity in both in vitro and in vivo systems.

conclusionBy combining different imaging modalities with melanin particles, we can use the complexes to obtain faster diagnoses by computed tomography deep-body imaging and greater detailed pathological diagnostic information by magnetic resonance imaging. The ion-doped melanin nanoparticles also have applications for radio-diagnostic treatment and radio imaging-guided surgery, warranting further proof of concept experimental.

Indexed as

AnimalsCell Line, TumorHumansIonsMagnetic Resonance ImagingMaleMelaninsMiceMice, Inbred BALB CMultimodal ImagingNanoparticlesNeoplasmsTomography, Emission-Computed, Single-PhotonTomography, X-Ray ComputedIonsMelaninsCancer imagingCTMelanin nanoparticleMRISPECT

Identifiers

PMID29017600
PMCPMC5635546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.